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ABSTRACT Three pancreatic beta-cell lines have been
established from insulinomas derived from transgenic mice
carrying a hybrid insulin-promoted simian virus 40 tumor
antigen gene. The beta tumor cell (J3TC) lines maintain the
features of differentiated beta cells for about 50 passages in
culture. The cells produce both proinsulin I and II and
efficiently process each into mature insulin, in a manner
comparable to normal beta cells in isolated islets. Electron
microscopy reveals typical beta-cell type secretory granules, in
which insulin is stored. Insulin secretion is inducible up to
30-fold by glucose, although with a lower threshold for max-
imal stimulation than that for normal beta cells. (3TC lines can
be repeatedly derived from primary beta-cell tumors that
heritably arise in the transgenic mice. Thus, targeted expres-
sion of an oncogene with a cell-specific regulatory element can
be used both to immortalize a rare cell type and to provide a
selection for the maintenance of its differentiated phenotype.
Pancreatic beta cells synthesize and secrete insulin, a hor-
mone involved in regulation of glucose homeostasis. In
rodents there are two nonallelic insulin genes (I and II), which
differ in the number of introns as well as in chromosomal
location. Both genes are expressed in beta cells (1). An adult
murine pancreas contains about 106 beta cells, clustered in
the islets of Langerhans, which are dispersed throughout the
exocrine tissue. As a consequence, molecular analyses of
beta-cell function has in large part depended on in vitro
cultures. Cells from isolated islets do not grow well in culture,
although they maintain viability for a few weeks (2). In recent
years, several lines of transformed beta cells have been
generated (3-6). Two of these, RIN-m SF, derived from an
x-ray-induced rat insulinoma, and HIT, from hamster islets
transformed by simian virus 40, have been used extensively
for characterization of insulin gene expression (4, 5, 7, 8).
However, it is unclear to what extent they represent normal
beta cells, given that the levels of insulin secreted are
considerably lower than those of beta cells in vivo.
The ability to target expression of oncogenes to particular
cells in transgenic mice, by using cell-specific regulatory
elements, presents a method for immortalization of rare cell
types. We have reported that transgenic mice harboring
insulin-simian virus 40 tumor (T) antigen (RIP-Tag) hybrid
genes heritably develop beta-cell tumors (9-11). Here we
describe the characterization of several beta tumor cell (J3TC)
lines obtained from transgenic mouse tumors and propagated
in culture for over 60 passages. These cells provide a useful
tool for studies of beta-cell regulation and gene expression.
METHODS
Cell Cultures. Pancreatic insulinomas were excised from
transgenic mice and disrupted in Dulbecco's modified Ea-
gle's medium (DMEM). To minimize contamination by
fibroblasts and other nontransformed cells, the tumors were
not trypsinized. Rather, the tumor capsule was gently re-
moved, and the tumor cells were mechanically dispersed.
After one wash, they were plated in 12-well plates (Coming)
at about 106 cells per well, in DMEM containing 25 mM
glucose and supplemented with 15% horse serum (GIBCO),
2.5% fetal bovine serum (Armour, Kankakee, IL), penicillin
(100 units/ml), and streptomycin (0.1 mg/ml) and incubated
in humidified 5% C02/95% air at 370C. When cells reached
about 50% confluency, they were transferred to 100-mm
plates (Falcon) by trypsinization with 0.05% trypsin/0.5 mM
EDTA. The cells were then subcultured approximately every
7 days and refed twice a week. The cells can be frozen in 90%6
fetal bovine serum/10%o dimethyl sulfoxide and thawed with
good viability after storage in liquid nitrogen.
HIT cells (6) (clone T15) were grown in DMEM containing
25 mM glucose and supplemented with 15% horse serum and
2.5% fetal bovine serum. RINr cells (clone 1046-38) were
obtained from W. L. Chick (University of Massachusetts
Medical School, Worcester) and were grown in either me-
dium 199 (GIBCO) supplemented with 5% fetal bovine serum
or in a serum-free RPMI 1640 medium supplemented with
hormones and growth factors as described (12).
HPLC Analysis of Insulin Peptides. Cells were incubated at
3-5 x 105 cells per ml for 30 min in leucine- and methionine-
free RPMI 1640 medium supplemented with 15% horse
serum, 2.5% fetal bovine serum, and 11 mM glucose or in
Krebs-Ringer bicarbonate medium supplemented with 20
mM Hepes, 5 mM NaHCO3, 0.2% bovine serum albumin,
penicillin (200 units/ml), streptomycin (0.2 mg/ml), and 2
mM L-glutamic acid (KRB medium) containing either 0.5 or
25 mM glucose. The cells were labeled with [3H]leucine (1
mCi/ml; 1 Ci = 37 GBq) and [35S]methionine (1 mCi/ml)
(Radiochemical Center, Amersham), followed by a chase
period of 30 min in nonradioactive complete RPMI. Islets
from both normal B6D2F1/J mice and from transgenic mice
of the RIP-Tag lineages were isolated (13) and pulse-chase
labeled as above. Tumors were similarly labeled. The cells
were homogenized by sonication and fractionated by re-
versed-phase HPLC by using a LiChrosorb RP-18 (5 ,um),
250-. x 4-mm column and eluted at 1 ml/min with a linear
gradient of acetonitrile (25-30%) in 0.125 M triethyl-
ammonium phosphate at pH 4.0. The column eluate was
collected in 0.3-ml fractions and monitored for 3H and 35S
radioactivity as well as for absorbance at 210 nm. Positive
Abbreviation: T antigen, tumor antigen.
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identification of the peaks was based both upon amino acid
sequencing and RIA (S.L., J. H. Nielsen, B. Hansen, and
B. S. Welinder, unpublished results).
Insulin RIA. Insulin was assayed by using guinea pig
anti-insulin serum (GP12), with monoiodinated porcine insu-
lin as tracer (14) and rat insulin (NOVO Industries, Bags-
vaerd, Denmark) as a standard. Bound and free insulin were
separated by using ethanol as described (15). The inter- and
intraassay coefficients of variation between duplicate sam-
ples were <10%.
Insulin Secretion: Perifusion. The column perifusion system
has been described (16). Cells at 30-50% confluency were
cultured in RPMI 1640 containing either 0.5 or 5 mM glucose
for 16 hr prior to perifusion. Preincubation in 0.5 mM glucose
resulted in 2- to 3-fold higher insulin peaks and was therefore
used in all the following experiments. Cells were detached
from the plate by a rubber policeman, mixed with Bio-Gel P-2
(200-400 mesh, Bio-Rad), placed in the columns, and peri-
fused at 0.25 ml/min with KRB medium supplemented with
different concentrations of glucose. Fractions were collected
over 5- to 10-min periods and analyzed by an insulin RIA.
Insulin Secretion and Insulin Content: Static Incubation.
Cells were passaged in 12-well plates 4-7 days prior to each
experiment and allowed to reach 30-40o confluency. The
cells were then washed twice in medium (RPMI 1640 or
DMEM) containing dialyzed serum and 0.5 mM glucose and
cultured for 16 hr. The medium was replaced with fresh
medium of the same type containing 5 mM glucose. Samples
were collected 2, 4, and 12 hr later, centrifuged briefly,
diluted 1:10 in NaFAM buffer [40 mM sodium phosphate, pH
7.4/0.1 M NaCl/bovine serum albumin (5 mg/ml)], and
stored at -20'C. The cells were detached with a rubber
policeman, centrifuged, homogenized in a small volume of
H20 by sonication, and then analyzed for DNA and insulin.
Samples for insulin analysis were extracted with 3 M acetic
acid, followed by freeze-drying and solubilization in NaFAM
buffer. DNA was determined fluorimetrically as described
(17).
Immunohistochemistry. Plates of /3TC cells were washed
in phosphate-buffered saline, fixed for 10 min at -20°C with
ice-cold acetone/methanol, 1:1 (vol/vol), and immuno-
stained essentially as described (10). Antibodies were used at
the following dilutions: guinea pig anti-insulin (Linco, Eureka,
MO), 1:100; rabbit-anti-T antigen (10), 1:5000; horseradish
peroxidase-conjugated goat anti-guinea-pig IgG and goat anti-
rabbit IgG (Accurate Chemicals, Westbury, NY), 1:200.
RNA Analysis. Isolation of RNA and Northern blotting
analysis have been described (10).
Electron Microscopy. Cells were trypsinized, fixed in 2%
glutaraldehyde, postfixed in 2% osmium tetroxide, solidified
in 2% agar, dehydrated, and embedded in PolyBed 812
(Polysciences, Warrington, PA). Thin sections (100 nm) were
poststained with uranyl acetate and lead citrate. For immu-
nogold staining, cells were fixed in 0.5% glutaraldehyde and
washed with sodium borohydride at 0.5 mg/ml. The cells
were pelleted in 2% agar, dehydrated, embedded, and sec-
tioned. Grids were incubated with 10%o H202 followed by
10% bovine serum albumin for 1 hr each. They were then
incubated with guinea pig anti-insulin antibody at a dilution
of 1:350 for 1 hr, washed, incubated with protein A-gold
particles [E-Y Laboratories (San Mateo, CA), 15 nmJ, diluted
1:20, poststained, and analyzed by EM.
RESULTS
Adaptation of Beta Tumor Cells to Growth in Culture. Cells
were initially dispersed from a tumor and plated at a relatively
high density in medium containing high serum concentra-
tions. These conditions have been found to be important for
the cells to attach to the plate and start dividing. In addition,
the combination of mechanical release of tumor cells from
carefully cleaned, encapsulated tumors with their subsequent
culture at high density in high concentrations of serum has
been found to reduce contamination by fibroblasts and other
nontransformed cells. The characterization of f3TC lines in
this report was performed with nonclonal cell cultures, of
which the best characterized thus far is 8TC1, which was
derived from a mouse in the RIP-Tag4 lineage. The cells grow
in clusters, which are relatively flat and well-attached initially
(Fig. 1) but tend to round and loosen their attachment to the
plate as cell mass in the cluster increases. After the first few
passages, the doubling time for the ETC1 line stabilized at
'-58 hr. The cells can be grown to about 50% confluency,
after which increased cell mortality is observed. In addition,
the cells do not proliferate well below 10o confluency.
Consequently, the cells cannot be easily cloned. fTC1 cells
analyzed for tumorigenicity in nude and histocompatible
B6D2F1/J mice after more than 30 passages have generated
subcutaneous beta-cell tumors, although at a markedly de-
creased incidence when compared to cell suspensions pre-
pared directly from tumors (data not shown).
The conditions developed during the establishment of the
/3TC1 line allow for reproducible derivation of new cell lines
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FIG. 1. Immunohistochemical analysis of insulin and large T
antigen in 83TC1 cells. Cells grown on tissue culture plates were
photographed at passage 7 with a research microscope under
phase-contrast (Top) or under bright-field illumination after immu-
nohistochemical staining with antibodies directed against insulin
(Middle) or large T antigen (Bottom). A different cluster of cells is
shown in each panel. (x450.)
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from primary tumors. To date, about 10 cell lines have been
established, of which 3 are described in this report.
Immunohistochemical Analysis of I3TC1 Cells. The expres-
sion of insulin and the insulin-promoted T-antigen transgene
in 3TC1 cells was analyzed by using immunohistochemical
techniques. As shown in Fig. 1, all the cells express both the
cell-specific marker (insulin) and the hybrid oncogene prod-
uct (T antigen). This indicates that other cell types do not
contaminate the cell population and therefore that the con-
ditions of establishing the cell cultures do not select for
sporadic activation of the hybrid oncogene in non-beta cells.
Some decrease in the intensity of the signal for both proteins
is observed after a large number ofpassages (>50). Two other
cell lines derived from the insulin-T-antigen transgenic mice,
denoted /3TC2 and (3TC3, show a similar pattern of immu-
nostaining (data not shown). The 8TC2 line is derived from
a tumor that developed in a mouse of the RIR-Tag2 lineage
(10). The I3TC3 line originated from a tumor that arose in a
mouse from a third independent lineage (RIP-Tag2).
A weak glucagon immunoreactivity appears in all the cells
of these three lines after a few passages in culture (data not
shown). Moreover, they secrete glucagon, which amounts to
1% (molar ratio) ofthe insulin secretion (J. Habener, personal
communication).
Analysis of Insulin Biosynthesis in BTC1 Cells. Synthesis
and processing of insulin I and II in f3TC1 cells has been
compared to that of normal mouse islets by using reversed-
phase HPLC analysis. This method allows the separation of
proinsulins, C-peptides, and mature insulins I and II. The
ratio between newly synthesized proinsulin I and II was
-1:2. However, the ratio between I and II was reversed for
both newly synthesized mature insulins and C-peptides,
which indicates a slower conversion of proinsulin II (Fig. 2).
Analysis of normal mouse islets (Fig. 2 Inset) and transgenic
islets and tumors (data not shown) revealed the same con-
version rate and relative proportions between newly synthe-
sized proinsulins, mature insulins, and C-peptides I and II as
those in ,TC1 cells.
The HPLC fractions were also analyzed for absorption at
210 nm, to assess the relative amounts of peptides stored in
the cells (data not shown). In this analysis, only the mature
insulin I and II could be detected. The proinsulins were not
detected, which indicates that the majority of insulin stored
in the cells is present in the mature form. The failure to detect
stored C-peptides is consistent with previous studies (ref. 18;
S.L., J. H. Nielsen, B. Hansen, and B. S. Welinder, unpub-
lished results). The ratio between stored insulins I and II was
about 1:2, which is similar to that of the newly synthesized
proinsulins and comparable to the pattern of stored insulin
observed in normal mouse islets. Therefore, it appears that
,BTC1 cells have a normal pattern of insulin biosynthesis,
conversion, and storage.
Glucose Induction ofInsulin Secretion from 8TC1 Cells. The
short-term response ofisolated islets to an increase in glucose
levels in the culture medium is the release from the cells of
insulin stored in secretory granules. To evaluate the response
of jTC1 cells to glucose, the cells were mixed with a gel
matrix and placed in a column for perifusion analyses. The
cells were first perifused for 40 min without glucose to
establish a basal level of insulin release (=0.2 microunits per
,ug ofDNA per min). Stimulation by 5 mM glucose resulted
in a 27.5 (+3.7)-fold (mean ±SD) increase in insulin release
in the first fraction sampled over a 5-min period (Fig. 3).
Insulin secretion gradually decreased thereafter. Perifusion
experiments at 1.25, 2.5, and 3.75 mM glucose showed that
a maximum stimulation of insulin secretion was reached at
1.25 mM glucose. The extent of induction and the secretion
profile closely resemble those ofcultured normal mouse islets
(16). However, the latter require 15 mM glucose for optimal
o mM glucose 5 mM glucose
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FIG. 2. Biosynthesis and conversion of insulin in 83TC1 cells.
Cells between passages 39 and 44 were pulse-chase labeled (30-min
pulse, 30-min chase) with [35S]methionine and [3H]leucine in KRB
medium containing 25 mM glucose, and cell homogenates were
fractionated by reversed-phase HPLC. The fractions were analyzed
for 3H and 31S radioactivity. The peaks are labeled as follows: Cl,
C-peptide I; C2, C-peptide II; Il, insulin I; I2, insulin II; PI, proinsulin
I; P2, proinsulin II. Positive identification of the peaks was based
both upon amino acid sequencing and RIA. Insulins I and II have
identical numbers of leucine residues. Only proinsulin II and insulin
II contain methionine. Comparable results were obtained with cells
labeled in either RPMI 1640 medium with 11 mM glucose or KRB
medium containing 0.5 mM glucose. (Inset) Analyses of normal
mouse islets. Islets have a major nonidentified peptide (containing
methionine but no leucine) that migrates between C-peptide I and
C-peptide II. This peptide is not present in STC1 cells.
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FIG. 3. Induction of insulin release from fBTC1 cells by glucose.
Cells between passages 42 and 50 were cultured for 16 hr in RPMI
1640 medium containing 0.5 mM glucose and then perifused in a gel
matrix with KRB medium containing the indicated glucose concen-
trations. Fractions (5 and 10 min) were collected for insulin RIA. The
data shown are the mean + SD of three experiments.
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stimulation (2, 19), which is at least 12-fold higher than the
levels required by BTC1 cells.
Insulin Release and Insulin Content of .lTC Cells in Static
Incubations. Table 1 shows the insulin release per day (24 hr)
and insulin content after culture in 5 mM glucose. The levels
of secreted insulin differ little between DMEM and RPMI
1640. However, insulin content is somewhat higher in the
latter. Glucose concentrations up to 25 mM induce similar
levels of both secreted and stored insulin (data not shown).
The analyses indicate that insulin protein synthesis and
secretion vary as a result of both passage number and the
tumor of origin. For example, a decrease in insulin secretion
by a factor of 10 was observed in 3TC1 between passages 50
and 63. Moreover, fTC2 cells secrete 6 times less insulin than
I3TC3 at similar passage numbers. Yet the steady-state levels
of insulin mRNA are similar in all three 83TC lines at the
passages analyzed in Table 1 (data not shown). The highest
figures obtained for insulin secretion and content (with ,8TC3
cells) are still several times lower than those of beta cells in
cultured normal mouse islets, which release 420 milliunits per
106 cells per day and contain 225 milliunits per 106 cells at
optimal glucose stimulation (15 mM) (19).
Analysis of Insulin and T-Antigen mRNAs in ,tTC1 Cells.
The abundance of insulin and T-antigen mRNAs in f3TC1
cells is very similar to that observed in the tumor tissue
obtained directly from transgenic mice (Fig. 4), which indi-
cates that growth in culture has not affected transcription of
either gene. The levels of these transcripts do not change
appreciably between 5 and 25mM glucose (Fig. 4) and remain
the same even following a 2-day incubation at 0.5 mM glucose
(data not shown).
,3TC1 cells contain much higher steady-state levels of
insulin mRNA than either HIT or RIN cells, as shown in Fig.
4. This corresponds to the higher amounts of insulin secreted
from /3TC1 cells compared to HIT cells (Table 1). These
results could be explained either by increased transcription of
the insulin genes or by greater stability of insulin mRNA in
/3TC1 cells.
Electron Microscopic Analysis of 3TC Cells. 3TC cells were
subjected to electron microscopic analysis to compare their
ultrastructure to that of normal beta cells (Fig. 5). In pan-
creatic tissue, beta cells are characterized by a high density
of insulin secretory granules (20), in which the processing
ofproinsulin takes place. Analysis oftransformed beta cells in
these transgenic mice (21) has shown that in vivo the tumor
cells have a characteristic beta-cell morphology, with a normal
number and distribution of insulin granules. In J3TC cells,
Table 1. Insulin secretion and content in /3TC lines
Insulin secretion,
Cell Passage milliunits per 106 Insulin content,
line no. Medium cells per day milliunits per 106cells
,8TC1 50 DMEM 43.7 ± 7.9 4.0 ± 0.6 (9)
63 DMEM 5.2 ± 0.5 4.1 ± 1.0 (79)
63 RPMI 4.0 ± 0.0 7.5 ± 0.7 (187)
I3TC2 15 DMEM 9.6 ± 0.0 16.9 ± 1.1 (176)
15 RPMI 9.4 ± 0.3 26.2 ± 0.6 (279)
fTC3 10 DMEM 53.4 ± 1.4 15.8 ± 3.0 (30)
10 RPMI 57.6 ± 5.2 46.7 ± 3.9 (81)
HIT ? DMEM 0.2 ± 0.0 <0.04
? RPMI 0.2 ± 0.1 <0.04
Cells were transferred from medium containing 0.5 mM glucose to
medium with 5 mM glucose. Two, 4, and 12 hr later aliquots of the
medium were collected and assayed for insulin. Following the 12-hr
incubation, cells were assayed for both insulin and DNA content.
Mean values ± SD (n = 6 for secretion and n = 2 for content) are
shown. Cell number is calculated assuming 1 cell = 7 pg of DNA.
Numbers in parentheses represent insulin content as a percent of
insulin secretion. The precise passage number of the HIT cells is
unknown.
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FIG. 4. Northern blot analysis of RNA from 83TC1 cells. RNA
was extracted from the following: ETC1 cells at passage 31 grown in
DMEM containing 25mM glucose or after 48 hr in DMEM containing
5 mM glucose, tumor tissue obtained from a RIP-Tag mouse, HIT
cells, and RIN cells grown either in medium 199 (M199) or in
hormonally defined (HD) medium. Twenty micrograms of total RNA
was separated on a 1.1% formaldehyde/agarose gel, transferred to
nitrocellulose, and hybridized with nick-translated simian virus 40
DNA (A), mouse insulin I probe (B), or with both the insulin (i) probe
and a chicken 18-actin (a) plasmid (C). The actin band serves to
control for relative RNA levels and quality. RNA size markers are
indicated in kilobases.
typical insulin granules are observed (Fig. 5). Most ofthem are
of the mature type, characterized by a dense core, although a
few immature granules, appearing uniformly pale, are also
observed. The number of granules is low, when compared to
normal and transformed beta cells in the pancreas (21).
Immunoelectron microscopy was used to demonstrate that the
observed granules actually contain insulin. Cell sections in-
cubated with anti-insulin serum and labeled with protein A-
colloidal gold show specific immunoreactivity in the granules
(Fig. 6), which confirms their insulin content.
DISCUSSION
The results presented here demonstrate that the f3TC lines
possess many characteristics of differentiated beta cells in
normal mice. The cells synthesize and secrete considerable
.jp..
FIG. 5. Electron microscopic analysis of ETC3 cells. (a) Cells at
passage 12 were cultured overnight in DMEM containing 0.5 mM
glucose. Arrows indicate insulin secretory granules. N, nucleus. (b)
Magnification of the area in a marked by dashed lines.
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FIG. 6. Immunoelectron microscopy of f3TC1 cells. Cells at
passage 36 were cultured for 48 hr in DMEM containing 5 mM
glucose. They were then incubated with anti-insulin serum, followed
by protein A-gold particles. Specific signal is observed over insulin
granules (arrowheads). One insulin granule appears to have secreted
its contents (arrow). Control sections incubated with phosphate-
buffered saline instead of the primary antibody showed no reactivity.
amounts of insulin, as measured by RIA and by insulin
mRNA analysis. The secretion of insulin is regulated by
glucose, as revealed in column perifusion experiments.
Induction levels of up to 30-fold were obtained within
minutes after shifting the cells from no glucose to 5 mM
glucose. pTC1 cells are sensitive to much lower levels of
glucose, when compared to normal beta cells. They secrete
appreciable amounts of insulin at 0.5 mM and reach maximal
stimulation at 1.25 mM, in contrast to the 15-mM level
required for maximal stimulation of secretion from normal
mouse beta cells in intact cultured islets. This difference may
result from the presence of other cell types in intact islets,
which normally influence insulin secretion by beta cells.
Alternatively, the continuous proliferation may constrain the
cells to metabolize high levels of glucose and thereby abro-
gate their normal sensitivity and response to glucose. The
steady-state levels of insulin mRNA are not affected by
glucose concentrations between 0.5 and 25 mM. Although
lower levels (<0.5 mM) might reveal a potential regulation of
insulin biosynthesis by glucose, such levels are incompatible
with viability of 8TC cells.
,fTC cells produce low amounts of glucagon, as judged by
immunohistochemical and biochemical analysis, in contrast
to the tumors in vivo (9). In the case of RIN cells, the initial
radiation-induced insulinoma has given rise to clones pro-
ducing insulin, glucagon, and somatostatin in various com-
binations (22, 23). The appearance of glucagon immunoreac-
tivity in PTC cells indicates that they have undergone a
change in gene regulation during propagation in vitro, which
might be considered dedifferentiation, given that insulin and
glucagon are normally coexpressed during islet cell develop-
ment (24).
The features of 3TC cells are likely to render them useful
for studies on regulation of the insulin genes and on beta-cell
physiology, for the isolation of proteins that control insulin
gene expression, and perhaps for characterization ofbeta-cell
molecules involved in the autoimmune response in diabetes.
In contrast to the other insulinoma cell lines, the availability
of lineages of transgenic mice that heritably develop beta-cell
tumors allows for repeated derivation of cell lines from the
primary tumors. Thus adaptation and deviation from the
observed beta-cell phenotype can be regularly cross-checked
in vivo, and new cell lines can be established if the old lines
become anaplastic.
These results demonstrate that targeted expression of an
oncogene in transgenic mice, by using a cell-specific regula-
tory element, can be applied for immortalization and estab-
lishment in cell culture of a rare cell type. The use of
cell-specific control regions not only provides access to
dispersed, rare cells but also provides a selection for the
differentiated phenotype of those cells in culture. Thus, the
hybrid oncogene represents a type of feedback loop that on
the one hand induces continuous cell proliferation and on the
other requires that high level expression of a cell-specific
gene be maintained.
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